Results 171 to 180 of about 23,984,619 (356)
Optimal Hedging in Carbon Emission Markets Using Markov Regime Switching Models
Dennis Philip, Yukun Shi
openalex +1 more source
The Hierarchical Hidden Markov Model: Analysis and Applications
Shai Fine, Y. Singer, Naftali Tishby
semanticscholar +1 more source
Stagewise crop yield prediction with multisource functional indices
Abstract Index insurance design involves integrating weather data, soil moisture, phenology information, and satellite imagery, which presents challenges in data fusion. This article addresses the modelling of multisource functional indices of varying lengths by constructing a stagewise ensemble of sequential models.
Jing Zou, Ostap Okhrin
wiley +1 more source
The hidden Markov model and its applications in bioinformatics analysis. [PDF]
Ma Y +17 more
europepmc +1 more source
A goodness‐of‐fit test for regression models with discrete outcomes
Abstract Regression models are often used to analyze discrete outcomes, but classical goodness‐of‐fit tests such as those based on the deviance or Pearson's statistic can be misleading or have little power in this context. To address this issue, we propose a new test, inspired by the work of Czado et al.
Lu Yang +2 more
wiley +1 more source
Economic evaluation of hypertension screening in Iran using a Markov model. [PDF]
Daroudi R +3 more
europepmc +1 more source
Fourier Mass Lower Bounds for Batchelor‐Regime Passive Scalars
ABSTRACT Batchelor predicted that a passive scalar ψν$\psi ^\nu$ with diffusivity ν$\nu$, advected by a smooth fluid velocity, should typically have Fourier mass distributed as |ψ̂ν|2(k)≈|k|−d$|\widehat{\psi }^\nu |^2(k) \approx |k|^{-d}$ for |k|≪ν−1/2$|k| \ll \nu ^{-1/2}$.
William Cooperman, Keefer Rowan
wiley +1 more source
Noise reduction of low-dose electron holograms using the wavelet hidden Markov model. [PDF]
Tomita Y +3 more
europepmc +1 more source
Straight to Phase III: Model‐informed approach speeds depemokimab clinical development in interleukin‐5‐driven diseases. IL‐5, a key mediator of type 2 inflammation, underlies various diseases, including severe asthma, CRSwNP, EGPA, and HES. Reduction in blood eosinophil count (BEC), a biomarker of IL‐5 activity, is commonly used to evaluate the ...
Chiara Zecchin +6 more
wiley +1 more source

